FindTrial
Sign In

Gonadotropins- letrozole, gonadotropin- clomiphene citrate, and gonadotropins only for controlled ovarian super stimulation in women with polycystic ovary syndrome undergoing intracytoplasmic sperm injection.

Gonadotropins- letrozole, gonadotropin- clomiphene citrate, and gonadotropins only for controlled ovarian super stimulation in women with polycystic ovary syndrome undergoing intracytoplasmic sperm injection.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202202892502375
Enrollment
150
Registered
2022-02-01
Start date
2018-10-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertility-female

Interventions

gonadotropin only
clomiphene citrate group
aromatase inhibitor group

Sponsors

suez canal university
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: a) women aged 20- 40 years, b) body mass index (BMI) 20- 35, c) first trial for ICSI, d) presenting with primary infertility, e) euthyroid, and f) normal serum prolactin.

Exclusion criteria

Exclusion criteria: a) previous pelvic surgery, b) chronic illnesses, and c) women refusing to participate in the study.

Design outcomes

Primary

MeasureTime frame
successful results regarding number of mature follicles, number of embryos resulted, pregnancy rates and liv birth rates—

Secondary

MeasureTime frame
side effects of each regimen and its cost—

Countries

Egypt

Contacts

Public Contactomima tharwat

assistant professor

omimatharwat@yahoo.com01223423685

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026